CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
Recruiting · NCT06136364 · Registry updated 2023-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-lymphoblastic lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2023-11-18 | NCT06136364 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hebei Senlang Biotechnology Inc., Ltd. | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Ruijin Hospital | Shanghai | China | 5 |